Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know.
1PCI, used appropriately (including some subsets of multivessel disease and left main stem stenosis) can be a very effective and worthwhile intervention. My criticisms, however, are aimed at its increasing, inappropriate, and non-evidence-based use in the wider population of patients with multivesse...
第一著者: | Taggart, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2006
|
類似資料
-
Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease
著者:: Hristo Kirov, 等
出版事項: (2023-12-01) -
Plastics of the left ventricle aneurysm with minimally invasive multivessel coronary artery bypass grafting
著者:: V.M. Demianenko, 等
出版事項: (2019-10-01) -
Features of Cardiopulmonary Bypass in Mininvasive Multivessel Coronary Artery Bypass Grafting
著者:: V. M. Demianenko, 等
出版事項: (2019-05-01) -
Lessons learned from the SYNTAX trial for multivessel and left main stem coronary artery disease.
著者:: Taggart, D
出版事項: (2011) -
Coronary-artery bypass surgery versus stenting for multivessel disease.
著者:: Taggart, D, 等
出版事項: (2001)